Learners who claimed credit for Recurrent Chronic Rhinosinusitis with Nasal Polyps with Slow and Limited Response to Dupilumab (November 2025) in the JACI: In Practice must complete this follow-up survey about the article and its impact on your practice to receive the additional 1.00 MOC Part II credit from the ABAI.